SOX2 and cancer: current research and its implications in the clinic

por Weina, Kasia, Utikal, Jochen
Publicado 2014

Tackling malignant melanoma epigenetically: histone lysine methylation

por Orouji, Elias, Utikal, Jochen
Publicado 2018

Stem Cell-Derived Models of Neural Crest Are Essential to Understand Melanoma Progression and Therapy Resistance

por Larribère, Lionel, Utikal, Jochen
Publicado 2019

Update on GNA Alterations in Cancer: Implications for Uveal Melanoma Treatment

por Larribère, Lionel, Utikal, Jochen
Publicado 2020

New Biomarkers in Cancers

por Novak, Daniel, Utikal, Jochen
Publicado 2021

NF1-Dependent Transcriptome Regulation in the Melanocyte Lineage and in Melanoma

por Larribère, Lionel, Utikal, Jochen
Publicado 2021

Melanoma Cellular Plasticity

por Novak, Daniel, Utikal, Jochen
Publicado 2022

Serologic and immunohistochemical prognostic biomarkers of cutaneous malignancies

por Utikal, Jochen, Schadendorf, Dirk, Ugurel, Selma
Publicado 2007

Systemic Therapy of Non-Resectable Metastatic Melanoma

por Orouji, Azadeh, Goerdt, Sergij, Utikal, Jochen
Publicado 2010

Role of STAT3 dependent SOX2 and CD24 expression in melanoma cell adaptive resistance towards targeted therapies

por Hüser, Laura, Altevogt, Peter, Utikal, Jochen
Publicado 2019

Case report: Therapeutic potential of T-VEC in combination with MEK inhibitors in melanoma patients with NRAS mutation

por Simon, Sonja C. S., Müller, Verena, Utikal, Jochen S.
Publicado 2023

The Role of Myeloid-Derived Suppressor Cells (MDSC) in Cancer Progression

por Umansky, Viktor, Blattner, Carolin, Gebhardt, Christoffer, Utikal, Jochen
Publicado 2016

Cellular Reprogramming—A Model for Melanoma Cellular Plasticity

por Granados, Karol, Poelchen, Juliane, Novak, Daniel, Utikal, Jochen
Publicado 2020

Leukocyte Count Restoration Under Dabrafenib Treatment in a Melanoma Patient With Vemurafenib-Induced Leukopenia: Case Report

por Orouji, Elias, Ziegler, Birgit, Umansky, Viktor, Gebhardt, Christoffer, Utikal, Jochen
Publicado 2014

STAT3 Relays a Differential Response to Melanoma-Associated NRAS Mutations

por Kim, James, Novak, Daniel, Sachpekidis, Christos, Utikal, Jochen, Larribère, Lionel
Publicado 2020

Neutrophils in Tumorigenesis: Missing Targets for Successful Next Generation Cancer Therapies?

por Tolle, Fabrice, Umansky, Viktor, Utikal, Jochen, Kreis, Stephanie, Bréchard, Sabrina
Publicado 2021

Oncogenic Role of an Epigenetic Reader of m(6)A RNA Modification: YTHDF1 in Merkel Cell Carcinoma

por Orouji, Elias, Peitsch, Wiebke K., Orouji, Azadeh, Houben, Roland, Utikal, Jochen
Publicado 2020

Unique Role of Histone Methyltransferase PRDM8 in the Tumorigenesis of Virus-Negative Merkel Cell Carcinoma

por Orouji, Elias, Peitsch, Wiebke K., Orouji, Azadeh, Houben, Roland, Utikal, Jochen
Publicado 2020

Enhancing immunotherapy response in melanoma: myeloid-derived suppressor cells as a therapeutic target

por Ozbay Kurt, Feyza Gul, Lasser, Samantha, Arkhypov, Ihor, Utikal, Jochen, Umansky, Viktor
Publicado 2023

Multiple epidermotropic melanoma metastases developing during BRAF and MEK inhibitor therapy

por Reinhard, Raphael, Gebhardt, Christoffer, Maurier, Nolwenn, Larribère, Lionel, Orouji, Azadeh, Utikal, Jochen
Publicado 2018